According to the new market research report “Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023", published by MarketsandMarkets™, The oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period.Factors such as the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of oncology-based nutritionAccess Free Sample Research Copy: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166703967
“The study answers several questions for stakeholders, primarily which market segments to focus in the next five years for prioritizing efforts & investments and competitive landscape of the market.”Oncology Nutrition Market segmented into :> The report analyzes the oncology nutrition market by type of cancer and region. Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake.> Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967Geographical Growth Analysis:Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2018 to 2023. The growth of this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.Key Players and Strategies Adopted by Them:Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B.Braun Melsungen AG (Germany). The other players in this market include Mead Johnson Nutrition Company (US), Hormel Foods (US), Meiji Holdings (Japan), Victus (US), and Global Health Products (US).Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=166703967
According to the new market research report “Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023", published by MarketsandMarkets™, The oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period.Factors such as the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of oncology-based nutrition formulas.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967 
The report analyzes the oncology nutrition market by type of cancer and region. Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake. Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.Browse and in-depth TOC on " Oncology Nutrition Market "11 – Tables23 - Figures92 - PagesOncology Nutrition Market segmented into :> The report analyzes the oncology nutrition market by type of cancer and region. Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake.> Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.Get Sample Copy of This Report@https://www.marketsandmarkets.com/requestsampleNew.asp?id=166703967Geographical Growth Analysis:Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2018 to 2023. The growth of this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.
According to the new market research report "Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).Don’t miss out on business opportunities in Oncology Nutrition Market.Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=166703967
Factors such as the shift from parenteral to enteral nutrition along with the increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the growth of the oncology nutrition market.Furthermore, the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of excipients. However, the complications associated with tube feeding and limited reimbursements represent a significant challenge to the market growth. The oncology nutrition market is expected to reach USD 2.21 Billion by 2023 from an estimated USD 1.46 Billion in 2018, at a CAGR of 8.7% during the forecast period.Browse and in-depth TOC on " Oncology Nutrition Market "11 – Tables23 - Figures92 - PagesRequest for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=166703967Based on type of cancer, the head and neck cancers segment accounted for the largest share of the oncology nutrition market, in 2017. This can be attributed to the use of tube feeding formulas for patients with head and neck cancers as conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting in these patients limits nutritional intake.Download an Illustrative overview of the report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967North America accounted for the largest share of the oncology nutrition market in 2017, followed by Europe. This regional segment shows significant market growth owing to the increasing prevalence of chronic diseases and disorders, coupled with rapidly growing aging population, which shows greater susceptibility to chronic and acute disorders than other population segments. In addition, long-term care facilities such as homecare & hospices, nursing homes, and assisted living facilities have emerged as efficient alternatives to hospitals. Furthermore, owing to cost-cutting pressures in hospitals, the healthcare system has seen a shift from extended hospital treatment to treatment at home, which is expected to propel the demand for such feeding formulas.The prominent players in the oncology nutrition market are Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B. Braun Melsungen AG (Germany).
The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083
What the Market Looks Like?
Predicted to grow at a CAGR of 7.0% during the forecast period, the global Intraoperative Radiation Therapy Market projected to reach USD 68 million by 2024 from USD 48 million in 2019
Based on method, the market is segmented into electron IORT and intraoperative brachytherapy. The electron IORT segment is expected to grow at the highest rate in the market in 2019.
On the basis of application, the market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head & neck cancer, and other cancers. The breast cancer application segment is expected to dominate the market during the forecast period. This can be primarily attributed to factors such as the non-invasive nature of radiotherapy, rising incidence of breast cancer, and high success rates achieved with IORT.
Get Sample Copy of This Report
@https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083
What Drives the Market?
The growth of the global market for Intraoperative Radiation Therapy is primarily influenced by the following factors:
• Growing Global Prevalence of Cancer
• Technological Advancements
• Advantages of IORT Over EBRT
Geographical growth scenario of Intraoperative Radiation Therapy
The Asia Pacific region is one of the major revenue-generating regions in the market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries. Furthermore, increasing geriatric population, the growing incidence of cancer, and the rising acceptance of IORT procedures and devices are also driving the growth of this regional market
Leading market players and strategies adopted
EISS Group (Germany) and iCAD, Inc. (US) dominated the global intraoperative radiation therapy market. Other prominent players include IntraOp Medical Corporation (US), Ariane Medical Systems, Ltd. (UK), Sordina IORT Technologies S.p.A. (Italy), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc.(US), Elekta AB (Sweden), Varian Medical Systems, Inc. (US), and Eckert & Ziegler Group (Germany), among others.
Read More: https://www.marketsandmarkets.com/PressReleases/intraoperative-radiation-therapy.asp
